Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 281

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Modifiable and non-modifiable risk factors for pancreatic cancer: A review

Midha, Shallu, Chawla, Saurabh, Garg, Pramod Kumar·2016·Cancer Letters

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2016.07.022

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 108

  1. Edwards, 2014, Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer, 120, 1290, 10.1002/cncr.28509 · DOI · Paper page
  2. Ishikawa, 1980, Adenosquamous carcinoma of the pancreas, a clinicopathologic study and report of three cases, Cancer, 46, 1192, 10.1002/1097-0142(19800901)46:5<1192::AID-CNCR2820460519>3.0.CO;2-D · doi:10.1002/1097-0142(19800901)46:5<1192::aid-cncr2820460519>3.0.co;2-d
  3. Motojima, 1992, Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas, J. Surg. Oncol, 49, 58, 10.1002/jso.2930490114 · doi:10.1002/jso.2930490114
  4. Bray, 2002, Estimation of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer, 38, 99, 10.1016/S0959-8049(01)00350-1 · DOI · Paper page
  5. Lowenfels, 2002, Epidemiologic and etiologic factors of pancreatic cancer, Hematol. Oncol. Clin. North Am, 16, 1, 10.1016/S0889-8588(01)00003-X · DOI
  6. Lowenfels, 1997, Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis study group, J. Natl. Cancer Inst, 89, 442, 10.1093/jnci/89.6.442 · DOI · Paper page
  7. Wahi, 2009, Reproductive factors and risk of pancreatic cancer in women: a review of the literature, Ann. Epidemiol, 19, 103, 10.1016/j.annepidem.2008.11.003 · DOI
  8. Duell, 2009, Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC, Cancer Causes Control, 20, 1757, 10.1007/s10552-009-9408-x · doi:10.1007/s10552-009-9408-x
  9. Chawla, 2015, Am. J. Gastroenterol, 110, S1, 10.1038/ajg.2015.269 · doi:10.1038/ajg.2015.269
  10. Arnold, 2009, Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?, Cancer Epidemiol. Biomarkers Prev, 18, 2397, 10.1158/1055-9965.EPI-09-0080 · DOI
  11. Silverman, 2002, Why do black Americans have a higher risk of pancreatic cancer than white Americans?, Epidemiology, 14, 46
  12. Blackford, 2009, Genetic mutations associated with cigarette smoking in pancreatic cancer, Cancer Res, 69, 3681, 10.1158/0008-5472.CAN-09-0015 · DOI · Paper page
  13. Pernick, 2003, Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians, Pancreas, 26, 28, 10.1097/00006676-200301000-00006 · DOI
  14. Dong, 2000, Ki -ras point mutation in a p 53 expressions in human pancreatic cancer, a comparative study among Chinese, Japanese and Western patients, Cancer Epidemiol. Biomarkers Prev, 9, 279
  15. Song, 2000, Comparison of K-ras point mutation at codon 12 and p-21 expression in pancreatic cancer between Japanese and Chinese patients, J. Surg. Oncol, 75, 176, 10.1002/1096-9098(200011)75:3<176::AID-JSO5>3.0.CO;2-W · doi:10.1002/1096-9098(200011)75:3<176::aid-jso5>3.0.co;2-w
  16. Grunda, 2012, Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer, BMC Res. Notes, 5, 248, 10.1186/1756-0500-5-248 · DOI
  17. Longnecker, 2000, Racial difference in pancreatic cancer, comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks and Whites in the US, Pancreas, 21, 338, 10.1097/00006676-200011000-00003 · DOI
  18. Wolpin, 2009, ABO blood group and the risk of pancreatic cancer, J. Natl. Cancer Inst, 101, 424, 10.1093/jnci/djp020 · DOI · Paper page
  19. Wolpin, 2010, Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium, Cancer Res, 70, 1015, 10.1158/0008-5472.CAN-09-2993 · DOI · Paper page
  20. Amundadottir, 2009, Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer, Nat. Genet, 41, 986, 10.1038/ng.429 · DOI · Paper page
  21. Landi, 2009, Genetic predisposition and environmental risk factors to pancreatic cancer: a review of the literature, Mutat. Res, 681, 299, 10.1016/j.mrrev.2008.12.001 · DOI
  22. Bracci, 2012, Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms, Mol. Carcinog, 51, 53, 10.1002/mc.20778 · DOI · Paper page
  23. Stolzenberg-Solomon, 2001, Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers, Am. J. Epidemiol, 153, 680, 10.1093/aje/153.7.680 · DOI
  24. Yeo, 2015, Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma, Semin. Oncol, 42, 8, 10.1053/j.seminoncol.2014.12.002 · DOI
  25. Petersen, 2010, A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33, Nat. Genet, 42, 224, 10.1038/ng.522 · DOI · Paper page
  26. Low, 2010, Genome-wide association study of pancreatic cancer in Japanese population, PLoS ONE, 5, e11824, 10.1371/journal.pone.0011824 · DOI
  27. Wu, 2012, Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations, Nat. Genet, 44, 62, 10.1038/ng.1020 · DOI · Paper page
  28. Raimondi, 2009, Epidemiology of pancreatic cancer: an overview, Nat. Rev. Gastroenterol. Hepatol, 6, 699, 10.1038/nrgastro.2009.177 · DOI · Paper page
  29. Raimondi, 2007, Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors, Cancer Epidemiol. Biomarkers Prev, 16, 1894, 10.1158/1055-9965.EPI-07-0341 · DOI
  30. Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
  31. Lowenfel, 1993, Pancreatitis and the risk of pancreatic cancer, N. Engl. J. Med, 328, 1433, 10.1056/NEJM199305203282001 · DOI · Paper page
  32. Fernandez, 1995, Pancreatitis and the risk of pancreatic cancer, Pancreas, 11, 185, 10.1097/00006676-199508000-00012 · DOI
  33. Bansal, 1995, Pancreatitis is a risk factor for pancreatic cancer, Gastroenterology, 109, 247, 10.1016/0016-5085(95)90291-0 · DOI · Paper page
  34. Moghaddam, 2006, The effect of modifiable risk factors on pancreatic cancer mortality in population of the Asia–Pacific Region, Cancer Epidemiol. Biomarkers Prev, 15, 2435, 10.1158/1055-9965.EPI-06-0368 · DOI
  35. Gold, 1985, Diet and other risk factors for cancer of the pancreas, Cancer, 55, 460, 10.1002/1097-0142(19850115)55:2<460::AID-CNCR2820550229>3.0.CO;2-V · DOI
  36. Mack, 1986, Pancreas cancer and smoking, beverage consumption and past medical history, J. Natl. Cancer Inst, 76, 49
  37. Bueno De Mesquita, 1992, Aspects of medical history andexocrine carcinoma of the pancreas: a population based case control study in the Netherlands, Int. J. Cancer, 52, 17, 10.1002/ijc.2910520105 · DOI
  38. Raimondi, 2010, Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection, Best Pract. Res. Clin. Gastroenterol, 24, 349, 10.1016/j.bpg.2010.02.007 · DOI · Paper page
  39. Midha, 2016, Genetically determined chronic pancreatitis but not alcoholic pancreatitis is a strong risk factor for pancreatic cancer, Pancreas, 10.1097/MPA.0000000000000684 · DOI
  40. Malka, 2002, Risk of pancreatic adenocarcinoma in chronic pancreatitis, Gut, 51, 849, 10.1136/gut.51.6.849 · DOI · Paper page
  41. Bright, 1833, Cases and observations connected with disease of the pancreas and duodenum, Med. Chir. Trans, 18, 1, 10.1177/09595287330180P102 · DOI
  42. Bell, 1957, Carcinoma of the pancreas, I, a Clinical and pathological study of 609 necropsied cases, II. The relation of carcinoma of the pancreas to diabetes mellitus, Am. J. Pathol, 33, 499
  43. Green, 1958, Diabetes Mellitus is associated with primary carcinoma of the pancreas, Diabetes, 7, 308, 10.2337/diab.7.4.308 · DOI
  44. Clark, 1961, Diabetes Mellitus and primary carcinoma of the pancreas, BMJ, 2, 1259, 10.1136/bmj.2.5262.1259 · doi:10.1136/bmj.2.5262.1259
  45. Everhart, 1995, Diabetes mellitus as a risk factor for PC. A meta-analysis, JAMA, 273, 1605, 10.1001/jama.1995.03520440059037 · DOI
  46. Huxley, 2005, Type II diabetes and pancreatic cancer- a meta-analysis of 36 studies, Br. J. Cancer, 92, 2076, 10.1038/sj.bjc.6602619 · DOI · Paper page
  47. Bosetti, 2014, Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium, Ann. Oncol, 25, 2065, 10.1093/annonc/mdu276 · DOI · Paper page
  48. Bonelli, 2003, Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case control studying northern Italy, Pancreas, 27, 143, 10.1097/00006676-200308000-00007 · DOI
  49. Chari, 2005, Probability of pancreatic cancer following diabetes: a population based study, Gastroenterology, 129, 504, 10.1016/j.gastro.2005.05.007 · doi:10.1016/j.gastro.2005.05.007 · Paper page
  50. Friedman, 1993, Risk factors for pancreatic cancer: an exploratory study, Int. J. Epidemiol, 22, 30, 10.1093/ije/22.1.30 · DOI
  51. Adami, 1991, Cancer risk in patients with diabetes mellitus, Cancer Causes Control, 2, 307, 10.1007/BF00051670 · DOI · Paper page
  52. Shibata, 1994, A prospective study of pancreatic cancer in the elderly, Int. J. Cancer, 58, 46, 10.1002/ijc.2910580109 · DOI · Paper page
  53. Munigala, 2015, Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus, Clin. Transl. Gastroenterol, 6, e118, 10.1038/ctg.2015.44 · DOI
  54. Jee, 2005, Fasting serum glucose level and cancer risk in Korean men and women, JAMA, 293, 194, 10.1001/jama.293.2.194 · DOI · Paper page
  55. Stocks, 2009, Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts, PLoS Med, 6, e1000201, 10.1371/journal.pmed.1000201 · DOI · Paper page
  56. Arslan, 2010, Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan), Arch. Intern. Med, 170, 791, 10.1001/archinternmed.2010.63 · DOI · Paper page
  57. Ding, 2000, Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression, Pancreas, 21, 310, 10.1097/00006676-200010000-00014 · DOI
  58. Maisonneuve, 2010, Past medical history and pancreatic cancer risk: results from a multicenter case–control study, Ann. Epidemiol, 20, 92, 10.1016/j.annepidem.2009.11.010 · DOI
  59. Li, 2009, Anti-diabetic therapies affect risk of pancreatic cancer, Gastroenterology, 137, 482, 10.1053/j.gastro.2009.04.013 · DOI · Paper page
  60. Evans, 2005, Metformin and reduced risk of cancer of 25–37% in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7 · DOI · Paper page
  61. Cui, 2012, Diabetes and pancreatic cancer, Endocr. Relat. Cancer, 19, F9, 10.1530/ERC-12-0105 · DOI · Paper page
  62. Egan, 2014, Pancreatic safety of incretin-based drugs–FDA and EMA assessment, N. Engl. J. Med, 370, 794, 10.1056/NEJMp1314078 · DOI · Paper page
  63. Dobbins, 2013, The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011, ISRN Prev. Med, 2013, 10.5402/2013/680536 · DOI · Paper page
  64. Li, 2010, New strategies in pancreatic cancer: emerging epidemiological and therapeutic concepts, Clin. Cancer Res, 16, 4313, 10.1158/1078-0432.CCR-09-1942 · DOI
  65. Rebours, 2015, Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions(PanIN), Clin. Cancer Res, 21, 3522, 10.1158/1078-0432.CCR-14-2385 · DOI · Paper page
  66. Feakins, 2016, Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract, Histopathology, 68, 630, 10.1111/his.12907 · DOI
  67. Zheng, 2009, Well-done meat intake, heterocyclic amine exposure, and Cancer risk, Nutr. Cancer, 61, 437, 10.1080/01635580802710741 · DOI · Paper page
  68. Schernhammer, 2005, Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts, Cancer Epidemiol. Biomarkers Prev, 14, 2098, 10.1158/1055-9965.EPI-05-0059 · DOI
  69. Larsson, 2006, Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study, Am. J. Clin. Nutr, 84, 1171, 10.1093/ajcn/84.5.1171 · DOI · Paper page
  70. Mueller, 2010, Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study, Cancer Epidemiol. Biomarkers Prev, 19, 447, 10.1158/1055-9965.EPI-09-0862 · DOI
  71. Bae, 2009, Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review, Pancreas, 38, 168, 10.1097/MPA.0b013e318188c497 · DOI
  72. Nöthlings, 2007, Flavonols and pancreatic cancer risk: the Multiethnic Cohort Study, Am. J. Epidemiol, 166, 924, 10.1093/aje/kwm172 · DOI · Paper page
  73. Stolzenberg-Solomon, 2001, Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers, Am. J. Epidemiol, 153, 680, 10.1093/aje/153.7.680 · DOI
  74. Larsson, 2006, Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men, J. Natl. Cancer Inst, 98, 407, 10.1093/jnci/djj094 · DOI
  75. Gong, 2009, Intake of folate, vitamins B(6), B(12) and methionine and risk of pancreatic cancer in a large population-based case-control study, Cancer Causes Control, 20, 1317, 10.1007/s10552-009-9352-9 · DOI
  76. Giovannucci, 2009, Vitamin D and cancer incidence in the Harvard cohorts, Ann. Epidemiol, 19, 84, 10.1016/j.annepidem.2007.12.002 · DOI · Paper page
  77. Bao, 2010, Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies, Br. J. Cancer, 102, 1422, 10.1038/sj.bjc.6605658 · DOI
  78. Fink, 1983, Increased plasma pancreatic polypeptide in chronic alcohol abuse, Clin. Endocrinol. (Oxf), 18, 417, 10.1111/j.1365-2265.1983.tb00587.x · doi:10.1111/j.1365-2265.1983.tb00587.x
  79. Lieber, 1979, Alcohol related diseases and carcinogenesis, Cancer Res, 39, 2863
  80. Stewart, 2001, Alcoholic liver disease: new insight into mechanisms and preventive strategies, Trends Mol. Med, 7, 408, 10.1016/S1471-4914(01)02096-2 · DOI · Paper page
  81. Agarwal, 1997, Molecular genetic aspects of alcohol metabolism and alcoholism, Pharmacopsychiatry, 30, 79, 10.1055/s-2007-979487 · doi:10.1055/s-2007-979487
  82. Velema, 1986, Alcohol and pancreatic cancer insufficient epidemiologic evidence for a causal relationship, Epidemiol. Rev, 8, 28, 10.1093/oxfordjournals.epirev.a036294 · DOI
  83. Hassan, 2007, Risk factors for pancreatic cancer: case control study, Am. J. Gastroenterol, 102, 2696, 10.1111/j.1572-0241.2007.01510.x · DOI · Paper page
  84. Wang, 2016, Association between alcohol intake and the risk of pancreatic cancer: a dose–response meta-analysis of cohort studies, BMC Cancer, 16, 212, 10.1186/s12885-016-2241-1 · DOI · Paper page
  85. Lowenfels, 2004, Epidemiology and prevention of pancreatic cancer, Jpn J. Clin. Oncol, 34, 238, 10.1093/jjco/hyh045 · DOI
  86. Maisonneuve, 2005, Cigarette smoking accelerates progression of alcoholic chronic pancreatitis, Gut, 54, 510, 10.1136/gut.2004.039263 · DOI · Paper page
  87. Chuang, 2011, Exposure to environmental tobacco smoke in childhood and incidence of cancer in adulthood in never smokers in the European Prospective Investigation into Cancer and Nutrition, Cancer Causes Control, 22, 487, 10.1007/s10552-010-9723-2 · DOI
  88. Lowenfels, 2001, Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis, JAMA, 286, 169, 10.1001/jama.286.2.169 · DOI · Paper page
  89. El-Serag, 2009, Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans, Hepatology, 49, 116, 10.1002/hep.22606 · DOI · Paper page
  90. Hassan, 2008, Association between hepatitis B virus and pancreatic cancer, J. Clin. Oncol, 26, 4557, 10.1200/JCO.2008.17.3526 · DOI · Paper page
  91. Risch, 2010, ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study, J. Natl. Cancer Inst, 102, 502, 10.1093/jnci/djq007 · DOI · Paper page
  92. Kim, 2016, Risk factors associated with loco-regional failure after surgical resection in patients with resectablepancreatic cancer, PLoS ONE, 11, e0157196, 10.1371/journal.pone.0157196 · doi:10.1371/journal.pone.0157196
  93. Asiyanbola, 2009, Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio, J. Gastrointest. Surg, 13, 752, 10.1007/s11605-008-0762-x · DOI
  94. Das, 2015, Pancreatic cancer metastasis: are we being pre-EMTed?, Curr. Pharm. Des, 21, 1249, 10.2174/1381612821666141211115234 · DOI
  95. Turner, 2012, Epidemiology: allergy history, IgE, and cancer, Cancer Immunol. Immunother, 61, 1493, 10.1007/s00262-011-1180-6 · DOI
  96. Turner, 2006, An overview of the association between allergy and cancer, Int. J. Cancer, 118, 3124, 10.1002/ijc.21752 · DOI
  97. Gandini, 2005, Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms, Cancer Epidemiol. Biomarkers Prev, 14, 1908, 10.1158/1055-9965.EPI-05-0119 · DOI
  98. Anderson, 2009, Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada, Cancer Causes Control, 20, 825, 10.1007/s10552-009-9303-5 · doi:10.1007/s10552-009-9303-5
  99. Lo, 2007, Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk, Pancreas, 35, 120, 10.1097/mpa.0b013e318053e7d3 · DOI
  100. Eppel, 2007, Allergies are associated with reduced pancreas cancer risk: a population-based casecontrol study in Ontario, Canada, Int. J. Cancer, 121, 2241, 10.1002/ijc.22884 · DOI
  101. Olson, 2012, Selected medical conditions and risk of pancreatic cancer, Mol. Carcinog, 51, 75, 10.1002/mc.20816 · DOI
  102. Gomez-Rubio, 2015, Reduced risk of pancreatic cancer associated with asthma and nasal allergies, Gut, 10.1136/gutjnl-2015-310442 · DOI
  103. Walker, 2015, Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study, Cancer, 121, 1287, 10.1002/cncr.29256 · DOI
  104. Jeon, 2015, The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis, PLoS ONE, 10
  105. Zhang, 2015, Aspirin might reduce the incidence of pancreatic cancer: a meta-analysis of observational studies, Sci. Rep, 5, 15460, 10.1038/srep15460 · DOI
  106. Larrson, 2006, Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis, Cancer Epidemiol. Biomarkers Prev, 15, 2561, 10.1158/1055-9965.EPI-06-0574 · DOI
  107. Wang, 2007, PancPRO: risk assessment for individuals with a family history of pancreatic cancer, J. Clin. Oncol, 25, 1417, 10.1200/JCO.2006.09.2452 · DOI · Paper page
  108. Ojajärvi, 2007, Estimating the relative risk of pancreatic cancer associated with exposure agents in job title data in a hierarchical Bayesian meta-analysis, Scand. J. Work Environ. Health, 33, 325, 10.5271/sjweh.1153 · DOI

Cited by

See all 281

Metadata

Authors
Midha, S., Chawla, S., & Garg, P. K.
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2016-10
Volume
381
Issue
1
Pages
269-277
ISSN
0304-3835 (ISSN-L)
OpenAlex
W2476900264
Cited by
281
References
5
FWCI
6.49
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modifiable and non-modifiable risk factors for pancreatic cancer: A review. https://app.cochat.ai/papers/10.1016/j.canlet.2016.07.022
The paper
Midha, S., Chawla, S., & Garg, P. K. (2016). Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Letters. https://doi.org/10.1016/j.canlet.2016.07.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.